EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between the Val66Met (rs6265) polymorphism of the brain-derived neurotrophic factor (BDNF) gene, BDNF protein level in the blood and the risk of developing early‑onset Parkinson’s disease

Iwona Przybylska, Jarosław Marusiak, Beata Toczyłowska, Adam Stępień, Bogdan Brodacki, Józef Langfort, Małgorzata Chalimoniuk

Acta Neurobiologiae Experimentalis · 07.10.2024

DOI: 10.55782/ane-2024-2476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neurobiologiae Experimentalis, online erschienen am 07.10.2024. Verfasst von Iwona Przybylska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiotherapy, Faculty of Physical Education and Health in Biala Podlaska, Józef Piłsudski University of Physical Education in Warsaw, …. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Parkinson Disease, Polymorphism, Single Nucleotide, Genetic Predisposition to Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain-derived neurotrophic factor (BDNF) is involved in the maintenance of dopamine level and the survival of dopaminergic neurons, which may affect the functionality of brain structures responsible for motor and cognitive function. The aim of the study was to assess the association of individual and combined single nucleotide polymorphism (SNP) in the rs6265 BDNF (Val66Met), rs397595 DAT (SLC6A3), and rs4680 COMT (Val158Met) genes with early‑onset of Parkinson’s disease (PD) patients. Moreover, we assessed the association between the BDNF Val66Met polymorphism and the level of BDNF protein in the serum of patients with PD and controls. The study involved 163 patients with idiopathic PD divided into early onset (55 years) groups and 91 healthy age‑matched people (Control). The SNP were determined using the TaqMan Real‑Time PCR method. Serum BDNF levels were determined by ELISA assay. The risk of developing early PD in people with the BDNF genotype AG increases threefold in comparison with the carriers of the BDNF genotype GG. In PD patients and healthy people with the BDNF genotypes AG and AA, a lower serum BDNF level was found compared to those with the BDNF genotype GG in both groups. The results of our study indicate that the presence of the Val66Met BDNF gene polymorphism is associated with reduced blood BDNF levels and an elevated risk of developing early‑onset PD. This effect appears to be more pronounced in men.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain-Derived Neurotrophic FactorParkinson DiseasePolymorphism, Single NucleotideGenetic Predisposition to DiseaseHumansMaleFemaleMiddle AgedAdultAgedAge of OnsetGenotypeDopamine Plasma Membrane Transport ProteinsCatechol O-MethyltransferaseGenetic Association StudiesCase-Control Studies

Substanzen

Brain-Derived Neurotrophic FactorBDNF protein, humanDopamine Plasma Membrane Transport ProteinsCatechol O-MethyltransferaseCOMT protein, humanSLC6A3 protein, human

Autor:innen und Institutionen

  • Department of Physiotherapy, Faculty of Physical Education and Health in Biala Podlaska, Józef Piłsudski University of Physical Education in Warsaw, Biala Podlaska, Poland.
  • Department of Kinesiology, Wroclaw University of Health and Sport Science, Wroclaw, Poland.
  • Department of Biophysical Measurements and Imaging, Institute of Biocybernetics and Biomedical Engineering Polish Academy of Sciences, Warsaw, Poland.
  • Clinic of Neurology, Military Institute of Medicine National Research Institute, Warsaw, Poland.
  • Institute of Sport Sciences, The Jerzy Kukuczka Academy of Physical Education, Katowice, Poland.
  • Department of Physiotherapy, Faculty of Physical Education and Health in Biala Podlaska, Józef Piłsudski University of Physical Education in Warsaw, Biala Podlaska, Pola.

Zitieren

APA

Przybylska, I., Marusiak, J., Toczyłowska, B., Stępień, A., Brodacki, B., Langfort, J., & Chalimoniuk, M. (2024). Association between the Val66Met (rs6265) polymorphism of the brain-derived neurotrophic factor (BDNF) gene, BDNF protein level in the blood and the risk of developing early‑onset Parkinson’s disease. Acta Neurobiologiae Experimentalis. https://doi.org/10.55782/ane-2024-2476

Vancouver

Przybylska I, Marusiak J, Toczyłowska B, Stępień A, Brodacki B, Langfort J, et al. Association between the Val66Met (rs6265) polymorphism of the brain-derived neurotrophic factor (BDNF) gene, BDNF protein level in the blood and the risk of developing early‑onset Parkinson’s disease. Acta Neurobiologiae Experimentalis. 2024. doi:10.55782/ane-2024-2476

BibTeX
@article{Przybylska2024,
  author = {Przybylska, Iwona and Marusiak, Jarosław and Toczyłowska, Beata and Stępień, Adam and Brodacki, Bogdan and Langfort, Józef and Chalimoniuk, Małgorzata},
  title = {Association between the Val66Met (rs6265) polymorphism of the brain-derived neurotrophic factor (BDNF) gene, BDNF protein level in the blood and the risk of developing early‑onset Parkinson’s disease},
  journal = {Acta Neurobiologiae Experimentalis},
  year = {2024},
  doi = {10.55782/ane-2024-2476}
}
Kostenlos starten →